Moderna starts dosing in Phase II Covid-19 vaccine trial
Participants will receive a 50μg, a 100μg dose or placebo at both vaccinations. Credit:
Jernej Furman.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more